In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reliant: The Expensive Opportunities in Primary Care

Executive Summary

Reliant's business model -- building a new company to sell the primary care products that looked too puny for Big Pharma -- posed management and financing challenges that almost killed the company. It's turned around, thanks to new management and a product in a hot area-lipids. But what's really got its investors excited: the opportunities posed by late-stage primary-care failures at Big Pharmas, who are now looking for market-proven products. And those Big Pharmas can help pay the acquisition cost by dismantling the costly infrastructure created to prove the product's value in the first place.
Advertisement

Related Content

Best Laid Plans: Pfizer's Torcetrapib Tanks
Best Laid Plans: Pfizer's Torcetrapib Tanks
The Acomplia Paradox: Primary Care Drug, Targeted Population
Endo: Accessing Primary Care through Specialist Marketing
Enzon: The Perils of Profitability
Enzon: The Perils of Profitability
Sepracor's Primary Care Ambitions
Opportunity Cost: How Alkermes Plans to Survive the Long Winter
Opportunity Cost: How Alkermes Plans to Survive the Long Winter
Alkermes Steps Toward the Market

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002699

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel